Quantification of cytomegalovirus viral load

Area of Science:

• Virology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Cytomegalovirus (CMV), a ubiquitous Herpesviridae member, establishes lifelong latent infections with reactivation potential.
• CMV poses severe risks, particularly to immunocompromised individuals, fetuses, and newborns.
• Traditional CMV detection methods are being superseded by more reliable techniques.

Purpose of the Study:

• To highlight the evolution of Cytomegalovirus (CMV) detection methodologies.
• To underscore the clinical significance of CMV quantification in diverse patient groups.
• To emphasize the importance of interdisciplinary collaboration in CMV management.

Main Methods:

• Review of current diagnostic approaches for Cytomegalovirus (CMV) detection.
• Comparison of classical CMV detection methods with quantitative nucleic acid tests (QNAT).
• Identification of key clinical indications for CMV DNA monitoring.

Main Results:

• Quantitative nucleic acid tests (QNAT) are increasingly replacing older methods like rapid culture and pp65 antigenemia assays.
• A wide array of QNAT, from lab-developed to commercial automated tests, are available.
• QNAT offers enhanced standardization and ease of implementation for CMV load monitoring.

Conclusions:

• Quantitative nucleic acid tests (QNAT) represent a significant advancement in Cytomegalovirus (CMV) diagnostics.
• Effective CMV management necessitates a strong partnership between clinical and virology teams.
• Optimized CMV DNA monitoring through QNAT is crucial for improving patient outcomes.